The microencapsulation process is used for size reduction with enclosing polymer coat on active pharmaceutical ingredient. The microencapsulation process used in present study is solvent evaporation process which formulated prior as o/o emulsification process. The polymer for encapsulation was selected based on drug entrapment efficiency and concentration of polymer mix was selected in ratio 1:2, further ratio was adjusted in central composite design for application of DOE in which independent variables was drug release after 2 hours and permeability across bio membrane after 4 hours. Results are shown revealed significant rise in bioavailability of drug than pure API. Scanning electron microscopy referred the size of microcapsule were in range of 10 -5000 m. They were spherical in shape with a rough surface and good solubility. Microcapsule were seen in SEM images are sphere with rough surfaces in all batches irrelevant of drug used. Drug encapsulation efficiencies of all the polymes were higher than 90%, which suggested that this method has potential to prepare microcapsules with efficient drug loading and increased bioavailability.
INTRODUCTION
In past few decades, biodegradable polymeric microcapsules are more focused as their potential in a wide range of biomedical applications. Microencapsulation is a process by which continuous film of polymeric material coated solid, liquid or even gaseous particles. These particles are in the size range of 1-1000 μm and are widely used as a drug carrier for controlled release. Poly Vinyl Pyrolidon are common and cheap biopolymers used in industry vastly as film forming agent to carry water-insoluble model drugs. Pyrolidones-based microcapsules of PVPK-30 1, 2, 3 , soluplus 4, 5 have been used as biodegradable layer for fast release drugs. Solvent evaporation techniques have become more useful method as compared to other methods. The particle size can be controlled in the nano to micrometer range can be possible by this method, but importance of careful selection of encapsulation materials and various conditions in order to achieve high encapsulation efficiency and a low residual solvent content should not be neglected. Solvent evaporation method 6 is investigated for preparing the Pyrolidones-based microcapsules as drug entrapment efficiency is high in this method.
Microspheres are formulated so as to maintain the concentration of drug in blood constantly and increase patient compliance, decrease dose and toxicity and the taste and odour of many drugs can be masked, liquid drugs can be converted into a free flowing powder, incompatibility among the drugs can be prevented 7 .
The statistical approach leads to prepare microcapsule with higher efficiency with higher throughput. The design Expert 9.0 used for development of microcapsule and desirability of final optimised batch can be evaluated with the help of contour and surface response plot suggested by design expert. Microsphere preparation by solvent extraction/ evaporation basically consists of four major steps:(i) dissolution or dispersion of the bioactive compound often in an organic solvent containing the matrix forming material; (ii) emulsification of this organic phase in a second continuous phase immiscible with the first one; (iii) extraction of the solvent from the dispersed phase by the continuous phase, which is optionally accompanied by solvent evaporation, either one transforming the droplets into solid microspheres; (iv) harvesting and drying of the microspheres 8 . For this stock solution of 1000µg/ml was prepared. Serial dilutions of 10, 20, 30, 40 µg/ml were prepared and absorbance was taken. Average of three sets of values were taken for standard calibration curve and solutions were scanned in the range of 200-400 nm against blank. The calibration curve was plotted. The preformulation studies carried out with the help of IR spectrophotometer and DSC study is carried out to study the thermal stability of the drug with presence of the different excipients 9 .
MATERIALS

FTIR Study
The FTIR study was performed for evaluation of drug and API interaction which was further studied with the Help of FTIR spectra arise with the any unusual graph pattern which was compared with standard spectra.
DSC Study
The DSC study was performed to get the idea of the interaction of drug and polymer in higher temperature and its affect at inert environment. The effect of the drug and polymer after microencapsulation process studied with DSC study.
Saturated Solubility Study
Saturated solubility study performed to evaluate the drug entrapment capacity of the polymer of drug. The microcapsule prepared with various concentration i.e 1:0.3, 1:0.5, 1:1, 1:2 by drug: polymer ratio respectively. The saturated solubility of each individual microcapsule studied by taking specified amount in glass vial containing water which rotated on lab shaker for 24 hours. The sample were prepared and diluted further for analysing drug contained in it 7, 8, 9, 11 .
Polymer Selection with Response Surface Methodology (RSM)
The polymer blend selected for preparation of microcapsule regarding the desired quality to be achieved after formulation of microcapsule such as drug solubility which leads to enhance drug dissolution and drug permeability which was evaluated with the help of in vitro methods. After stirring microcapsules are decanted and filtered. The microcapsules are washed severally with n-hexane to remove residual liquid paraffin. The final microcapsules are stored in tightly closed container for further development of dosage form 11,2 .
Characterization of Microcapsules
SEM Analysis
Surface Morphology of the microcapsule was investigated by scanning electron microscopy (SEM) using a JEOL JSM-6510 SEM. The microspheres were coated with gold before scanning to enhance their conductivity. The surface morphology can reveals by SEM image also the coated core material enclosed with coating polymer can be inferred.
Drug Entrapment Efficiency
Drug content which entrapped by polymers of the microcapsules were determined by UV-vis spectrophotometry. The microcapsule equivalent to 50 mg drug were dissolved in acetone 2ml and diluted with buffer solution. A clear solution was obtained for drug content measurement. Drug content values were the average from three experiments.
In vitro drug release study
The drug release profile was carried out with the help of drug dissolution apparatus Type 1 (Basket type). The microcapsule of single dose quantity filled in basket and rotated in dissolution flask containing buffer with temperature maintained at 37 ± 0.5°C for 2 hours. After specific time period the 2ml aliquote withdrawn from dissolution flask and exactly same quantity of same temperature buffer added in the flask to maintain sink condition. The aliquots were further diluted and ISSN: 2250-1177 CODEN (USA): JDDTAO analysed. The release profile of the drug carried out in triplicate 5 .
In Vitro Drug Permeability study
The drug permeability study includes the study of the drug formulation and its effect on the drug permeability through intestinal membrane. The vitro model selected for studying in vitro permeability of the drug was modified Wilson and crane apparatus for drug permeability measurement. In this study the everted gut sac of chicken illieum tied with glass tube which made pouch like structure open at one end with tied knot at other. Filled with buffer then dipped in bottle containing drug solution and aerated the whole system as well as maintained at 37 ±0.5° C
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The samples are withdrawn after specific time period from the attached tube of the gut section and filled with exactly same amount of fresh buffer added in it to maintain sink condition. The samples were further diluted and analysed. The samples were analysed triplicate by UV spectrophotometric analysis 4 .
RESULT AND DISCUSSION
The microcapsules prepared by this method were discrete and individual system with free flowing nature having nearly uniform size.
Preformulation Study Standard Calibration Curve
The drug evaluated for formulation before their formulation. The absorbance maxima of the individual drug determined with their respective buffer solutions. Standard Calibration Curve of Cefuroxime Axetil was prepared in 7.0 pH phosphate buffer at λ max 280 nm. Standard Calibration Curve of Cefpodoxime Proxetil was prepared in 3.0 pH phosphate buffer at λ max 233nm.Standerd Calibration Curve of Furosemide was prepared in 5.8 pH phosphate buffer λ max 274nm. Using UV-Visible spectrophotometer. For this stock solution of 1000 µg/ml was prepared. Serial dilutions of 5, 10, 15, 20, 25 µg/ml were prepared and absorbance was taken. Averages of 3 sets of values were taken for standard calibration curve, and solutions were scanned in the range 200-400 nm against blank. The calibration curve was plotted. The IR spectra of microcapsule having the same content as that of solid dispersion and showing exactly same graphs and formulation process not make any significant changes in structure of the drug in functional group hence indicating no interaction between drug and ingredients in microcapsules.
The IR spectra of microcapsule having the same content as that of solid dispersion and showing exactly same graphs a formulation process not make any significant changes in structure of the drug in functional group hence indicating no interaction between drug and ingredients in microcapsules. 
DSC Study
The DSC Graphs shows endothermic curve on 88.80°C. Also exothermic peak shows on 252°C (Fig.  74) for pure cefuroxime axetil. The microcapsule shows transition temperature 217.24°C which shows complete impingement of drug core inside carrier of polymers as shown in SEM image. 
Saturated Solubility Study
The solution gives the drug content as follows From above graph it can be suggested that amount of PVPK is more favourable for improvement of solubility and microencapsulation formation hence the polymer concentration was decided as 1:2 for Soluplus and PVPK respectively.
Formulation by Central Composite Design
The Design expert software 9.0 were used for determination of polymer concentration to be taken while formulation. Ratio of soluplus and PVPK kept at 1:2 respectively. The formulation decided with the help of results obtained from saturated solubility study of PVPK, Soluplus, and drug in respective Buffer. The formulation trials are as follows; The Batches are formulated according to the formula shown in table 2 for determination of bioavailability of the formulation. The microcapsules prepared by the above batches evaluated for drug release study and permeability study.
Characterization of Microspheres Scanning Electron Microscopy (SEM)
The SEM of drug performed and shows the distorted and irregular, rough shaped crystals of the drug having nonspecific size crystals with rough surface. In the SEM photograph of cefuroxime axetil after microencapsulation shows a small bead like structure with layer of coating polymer upon it leads to the conclusion of proper coating of small core of drug with polymer. 
Drug Entrapment Efficiency
The Drug entrapment study performed prior to drug release study for evaluating the drug loaded in the formulation in right proportion as well as the efficiency of process for drug entrapment for study release profile study evaluated for its release pattern with errors. The in vitro drug release profile shown by the coded batch as follows 
Figure 28: RSM plot for Effect on Dissolution by individual polymer Cefuroxime Axetil
From above RSM plot shows that the solubility of drug depends on the concentration of both polymers as concentration of polymer rises the solubility also increases but if compared individual polymer then it concluded that the PVPK 30 is more responsible to enhance the solubility of the drug. From above RSM plot shows that the permeability of drug depends on the concentration of Soluplus while PVPK 30 doesn't play any significant role in permeability enhancement
Desirability plot for polymer for bioavailability enhancement:
The desirability plot shows the most desirable concentration of the batch runs to achieve most efficient bioavailability with significant economical and efficient method.
Figure 30: Desirability plot for polymer use Cefuroxime Axetil
The in vitro drug release profile shown by the coded batch as follows From above RSM plot shows that the permeability of drug depends on the concentration of Soluplus while PVPK 30 doesn't play any significant role in permeability enhancement.
Desirability plot for polymer for bioavailability enhancement
The desirability plot shows the most desirable concentration of the batch runs to achive most efficient bioavailability with significant economical and efficient method. 
Final Equation in Terms of Coded Factors
The From above RSM plot shows that the permeability of drug depends on the concentration of Soluplus while PVPK 30 doesn't play any significant role in permeability enhancement
Desirability plot for polymer for bioavailability enhancement
The desirability plot shows the most desirable concentration of the batch runs to achive most efficient bioavailability with significant economical and efficient method. The in vitro drug release profile shown by the coded batch as follows 
